指南与共识乳腺癌

早期乳腺癌患者的前哨淋巴结活检:美国临床肿瘤学会临床实践指南更新

Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
指南 / 共识 · J Clin Oncol · 2016-12-12

美国临床肿瘤学会基于2012年至2016年7月的文献更新早期乳腺癌前哨淋巴结活检推荐,共识别并审查8篇出版物,未改变2014年推荐。无前哨淋巴结转移者不应行腋窝淋巴结清扫;1–2枚转移且计划保乳加全乳放疗者(多数情况)不应行腋窝淋巴结清扫;前哨淋巴结转移且拟行乳房切除者应接受腋窝淋巴结清扫。

要点

  • 无前哨淋巴结转移的早期乳腺癌女性不应接受腋窝淋巴结清扫。
  • 1–2枚前哨淋巴结转移且计划保乳加全乳放疗者,多数情况不应行腋窝淋巴结清扫。
  • 前哨淋巴结转移且拟行乳房切除者应接受腋窝淋巴结清扫。

核心结论

  • 无前哨淋巴结转移的女性不应接受腋窝淋巴结清扫。
  • 1–2枚前哨淋巴结转移且计划保乳手术加全乳放疗的女性,多数情况不应接受腋窝淋巴结清扫。
  • 前哨淋巴结转移且将接受乳房切除的女性应接受腋窝淋巴结清扫。
  • 上述三条推荐基于随机对照试验。

研究设计与样本

  • 美国临床肿瘤学会临床实践指南更新,检索PubMed和Cochrane图书馆2012年至2016年7月的随机对照试验、系统评价、Meta分析和临床实践指南。
  • 更新专家组审查共识别并审查8篇出版物。

主要发现

  • 8篇出版物中无一篇促使改变2014年推荐,更新文献审查重申2014年推荐。

关键数值与推荐

  • 无前哨淋巴结转移者不应行腋窝淋巴结清扫。
  • 1–2枚前哨淋巴结转移且计划保乳加全乳放疗者,多数情况不应行腋窝淋巴结清扫。
  • 前哨淋巴结转移且拟行乳房切除者应行腋窝淋巴结清扫。
  • 可手术乳腺癌伴多中心肿瘤、导管原位癌、将行乳房切除、既往乳腺和/或腋窝手术或接受术前/新辅助全身治疗者,可考虑前哨淋巴结活检。
  • 大或局部晚期浸润性乳腺癌(肿瘤大小T3/T4)、炎性乳腺癌、导管原位癌(计划保乳手术时)或妊娠者不应行前哨淋巴结活检。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Purpose To provide current recommendations on the use of sentinel node biopsy (SNB) for patients with early-stage breast cancer. Methods PubMed and the Cochrane Library were searched for randomized controlled trials, systematic reviews, meta-analyses, and clinical practice guidelines from 2012 through July 2016. An Update Panel reviewed the identified abstracts. Results Of the eight publications identified and reviewed, none prompted a change in the 2014 recommendations, which are reaffirmed by the updated literature review. Conclusion Women without sentinel lymph node (SLN) metastases should not receive axillary lymph node dissection (ALND). Women with one to two metastatic SLNs who are planning to undergo breast-conserving surgery with whole-breast radiotherapy should not undergo ALND (in most cases). Women with SLN metastases who will undergo mastectomy should be offered ALND. These three recommendations are based on randomized controlled trials. Women with operable breast cancer and multicentric tumors, with ductal carcinoma in situ, who will undergo mastectomy, who previously underwent breast and/or axillary surgery, or who received preoperative/neoadjuvant systemic therapy may be offered SNB. Women who have large or locally advanced invasive breast cancer (tumor size T3/T4), inflammatory breast cancer, or ductal carcinoma in situ (when breast-conserving surgery is planned) or are pregnant should not undergo SNB.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Lyman GH, Somerfield MR, Bosserman LD, et al. Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2016. PMID: 27937089. doi:10.1200/JCO.2016.71.0947

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。